JAK-STAT1/3-induced expression of signal sequence-encoding proopiomelanocortin mRNA in lymphocytes reduces inflammatory pain in rats

Molecular Pain

Volumn 8, Issue , 2012, Pages

  Busch Dienstfertig, Melanie ^a   Labuz, Dominika ^a   Wolfram, Theresa ^a,b   Vogel, Nicole N ^a   Stein, Christoph ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b MORPHOSYS AG   (Germany)

Author keywords

Cytokine signaling.; Immune cells; Inflammation; Neuro immune interactions; Opioid peptides; Pain

Indexed keywords

BETA ENDORPHIN; CONCANAVALIN A; INTERLEUKIN 4; JANUS KINASE; JANUS KINASE INHIBITOR; MESSENGER RNA; METHYL IODIDE; NALOXONE; OLIGONUCLEOTIDE; PROOPIOMELANOCORTIN; SIGNAL PEPTIDE; STAT1 PROTEIN; STAT3 PROTEIN; STAT6 PROTEIN;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY PAIN; LYMPHATIC DRAINAGE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFER; MALE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROOPIOMELANOCORTIN GENE; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ANIMALS; CELLS, CULTURED; CONCANAVALIN A; INFLAMMATION; INTERLEUKIN-4; JANUS KINASE 3; LYMPHOCYTES; MALE; NALOXONE; PAIN; PRO-OPIOMELANOCORTIN; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, WISTAR; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR;

EID: 84868667133     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-8-83     Document Type: Article

References (59)

1. Paulozzi LJ, Baldwin G, Kerlikowske RG, Jones CM, Ghiya N, Popovic T. CDC grand rounds: prescription drug overdoses - a U.S. epidemic. MMWR Morb Mortal Wkly Rep 2012, 61:10-13.
2. Sehgal N, Smith HS, Manchikanti L. Peripherally acting opioids and clinical implications for pain control. Pain Physician 2011, 14:249-258.
3. Stein C, Hassan AH, Lehrberger K, Giefing J, Yassouridis A. Local analgesic effect of endogenous opioid peptides. Lancet 1993, 342:321-324. 10.1016/0140-6736(93)91471-W, 8101583.
4. Likar R, Mousa SA, Steinkellner H, Koppert W, Philippitsch G, Stein C, Schäfer M. Involvement of intra-articular corticotropin-releasing hormone in postoperative pain modulation. Clin J Pain 2007, 23:136-142. 10.1097/01.ajp.0000210954.93878.0d, 17237662.
5. Schreiter A, Gore C, Labuz D, Fournie-Zaluski M-C, Roques BP, Stein C, Machelska M. Pain inhibition by blocking leukocytic and neuronal opioid peptidases in peripheral inflamed tissue FASEB J 2012. published ahead of print August 24 2012,
6. Stein C, Gramsch C, Herz A. Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin. J Neurosci 1990, 10:1292-1298.
7. Rittner HL, Labuz D, Schaefer M, Mousa SA, Schulz S, Schäfer M, Stein C, Brack A. Pain control by CXCR2 ligands through Ca2+-regulated release of opioid peptides from polymorphonuclear cells. Faseb J 2006, 20:2627-2629. 10.1096/fj.06-6077fje, 17060402.
8. Stein C, Schäfer M, Machelska H. Attacking pain at its source: new perspectives on opioids. Nat Med 2003, 9:1003-1008. 10.1038/nm908, 12894165.
9. Schäfer M, Carter L, Stein C. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci U S A 1994, 91:4219-4223. 10.1073/pnas.91.10.4219, 43756, 7910403.
10. Przewlocki R, Hassan AH, Lason W, Epplen C, Herz A, Stein C. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience 1992, 48:491-500. 10.1016/0306-4522(92)90509-Z, 1603330.
11. Hermanussen S, Do M, Cabot PJ. Reduction of beta-endorphin-containing immune cells in inflamed paw tissue corresponds with a reduction in immune-derived antinociception: reversible by donor activated lymphocytes. Anesth Analg 2004, 98:723-729.
12. Raffin-Sanson ML, Massias JF, Ankotche A, Coste J, de Keyzer Y, Oliver C, Dumont C, Cabrol D, Ferre F, Bertagna X. High precursor level in maternal blood results from the alternate mode of proopiomelanocortin processing in human placenta. Clin Endocrinol (Oxf) 1999, 50:85-94.
13. Heijnen CJ, Kavelaars A, Ballieux RE. Beta-endorphin: cytokine and neuropeptide. Immunol Rev 1991, 119:41-63. 10.1111/j.1600-065X.1991.tb00577.x, 2045122.
14. Westly HJ, Kleiss AJ, Kelley KW, Wong PK, Yuen PH. Newcastle disease virus-infected splenocytes express the proopiomelanocortin gene. J Exp Med 1986, 163:1589-1594. 10.1084/jem.163.6.1589, 2188131, 2872261.
15. Tanaka S. Comparative aspects of intracellular proteolytic processing of peptide hormone precursors: studies of proopiomelanocortin processing. Zoolog Sci 2003, 20:1183-1198. 10.2108/zsj.20.1183, 14569141.
16. Cabot PJ, Carter L, Gaiddon C, Zhang Q, Schäfer M, Loeffler JP, Stein C. Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats. J Clin Invest 1997, 100:142-148. 10.1172/JCI119506, 508174, 9202066.
17. Oates EL, Allaway GP, Armstrong GR, Boyajian RA, Kehrl JH, Prabhakar BS. Human lymphocytes produce pro-opiomelanocortin gene-related transcripts. Effects of lymphotropic viruses. J Biol Chem 1988, 263:10041-10044.
18. Lacaze-Masmonteil T, de Keyzer Y, Luton JP, Kahn A, Bertagna X. Characterization of proopiomelanocortin transcripts in human nonpituitary tissues. Proc Natl Acad Sci U S A 1987, 84:7261-7265. 10.1073/pnas.84.20.7261, 299272, 3478693.
19. DeBold CR, Menefee JK, Nicholson WE, Orth DN. Proopiomelanocortin gene is expressed in many normal human tissues and in tumors not associated with ectopic adrenocorticotropin syndrome. Mol Endocrinol 1988, 2:862-870. 10.1210/mend-2-9-862, 2845257.
20. van Woudenberg AD, Metzelaar MJ, van der Kleij AA, de Wied D, Burbach JP, Wiegant VM. Analysis of proopiomelanocortin (POMC) messenger ribonucleic acid and POMC-derived peptides in human peripheral blood mononuclear cells: no evidence for a lymphocyte-derived POMC system. Endocrinology 1993, 133:1922-1933. 10.1210/en.133.5.1922, 8404638.
21. Sitte N, Busch M, Mousa SA, Labuz D, Rittner H, Gore C, Krause H, Stein C, Schäfer M. Lymphocytes upregulate signal sequence-encoding proopiomelanocortin mRNA and beta-endorphin during painful inflammation in vivo. J Neuroimmunol 2007, 183:133-145. 10.1016/j.jneuroim.2006.11.033, 17223201.
22. Lyons PD, Blalock JE. Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes. J Neuroimmunol 1997, 78:47-56. 10.1016/S0165-5728(97)00081-7, 9307227.
23. Stephanou A, Fitzharris P, Knight RA, Lightman SL. Characteristics and kinetics of proopiomelanocortin mRNA expression by human leucocytes. Brain Behav Immun 1991, 5:319-327. 10.1016/0889-1591(91)90027-8, 1685686.
24. Lamolet B, Pulichino AM, Lamonerie T, Gauthier Y, Brue T, Enjalbert A, Drouin J. A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 2001, 104:849-859. 10.1016/S0092-8674(01)00282-3, 11290323.
25. Lamonerie T, Tremblay JJ, Lanctot C, Therrien M, Gauthier Y, Drouin J. Ptx1, a bicoid-related homeo box transcription factor involved in transcription of the pro-opiomelanocortin gene. Genes Dev 1996, 10:1284-1295. 10.1101/gad.10.10.1284, 8675014.
26. Kovalovsky D, Paez Pereda M, Labeur M, Renner U, Holsboer F, Stalla GK, Arzt E. Nur77 induction and activation are necessary for interleukin-1 stimulation of proopiomelanocortin in AtT-20 corticotrophs. FEBS Lett 2004, 563:229-233. 10.1016/S0014-5793(04)00303-5, 15063754.
27. Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F, Arzt E. Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways. Mol Endocrinol 2002, 16:1638-1651. 10.1210/me.16.7.1638, 12089357.
28. Yang G, Lim CY, Li C, Xiao X, Radda GK, Li C, Cao X, Han W. FoxO1 inhibits leptin regulation of pro-opiomelanocortin promoter activity by blocking STAT3 interaction with specificity protein 1. J Biol Chem 2009, 284:3719-3727.
29. Beyer CF, Bowers WE. Periodate and concanavalin A induce blast transformation of rat lymphocytes by an indirect mechanism. Proc Natl Acad Sci U S A 1975, 72:3590-3593. 10.1073/pnas.72.9.3590, 433041, 171668.
30. Cool DR, Loh YP. Identification of a sorting signal for the regulated secretory pathway at the N-terminus of pro-opiomelanocortin. Biochimie 1994, 76:265-270. 10.1016/0300-9084(94)90156-2, 7819333.
31. Scholzen TE, Kalden DH, Brzoska T, Fisbeck T, Fastrich M, Schiller M, Bohm M, Schwarz T, Armstrong CA, Ansel JC, Luger TA. Expression of proopiomelanocortin peptides in human dermal microvascular endothelial cells: evidence for a regulation by ultraviolet light and interleukin-1. J 2000, 115:1021-1028.
32. Katahira M, Iwasaki Y, Aoki Y, Oiso Y, Saito H. Cytokine regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. Endocrinology 1998, 139:2414-2422. 10.1210/en.139.5.2414, 9564853.
33. Fukata J, Usui T, Naitoh Y, Nakai Y, Imura H. Effects of recombinant human interleukin-1 alpha, -1 beta, 2 and 6 on ACTH synthesis and release in the mouse pituitary tumour cell line AtT-20. J Endocrinol 1989, 122:33-39. 10.1677/joe.0.1220033, 2549151.
34. Kamphuis S, Kavelaars A, Brooimans R, Kuis W, Zegers BJ, Heijnen CJ. T helper 2 cytokines induce preproenkephalin mRNA expression and proenkephalin A in human peripheral blood mononuclear cells. J Neuroimmunol 1997, 79:91-99. 10.1016/S0165-5728(97)00113-6, 9357452.
35. Wills-Karp M, Finkelman FD. Untangling the complex web of IL-4- and IL-13-mediated signaling pathways. Sci Signal 2008, 1:55.
36. Kraus J, Börner C, Giannini E, Hickfang K, Braun H, Mayer P, Hoehe MR, Ambrosch A, Konig W, Höllt V. Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J Biol Chem 2001, 276:43901-43908. Epub 42001 Sep 43925., 10.1074/jbc.M107543200, 11572871.
37. Ginsberg M, Czeko E, Muller P, Ren Z, Chen X, Darnell JE. Amino acid residues required for physical and cooperative transcriptional interaction of STAT3 and AP-1 proteins c-Jun and c-Fos. Mol Cell Biol 2007, 27:6300-6308. 10.1128/MCB.00613-07, 2099614, 17636030.
38. Mynard V, Guignat L, Devin-Leclerc J, Bertagna X, Catelli MG. Different mechanisms for leukemia inhibitory factor-dependent activation of two proopiomelanocortin promoter regions. Endocrinology 2002, 143:3916-3924. 10.1210/en.2002-220323, 12239103.
39. Acaciade Sa Pinheiro A, Morrot A, Chakravarty S, Overstreet M, Bream JH, Irusta PM, Zavala F. IL-4 induces a wide-spectrum intracellular signaling cascade in CD8+ T cells. J Leukoc Biol 2007, 81:1102-1110. 10.1189/jlb.0906583, 17200144.
40. Wen Z, Darnell JE. Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3. Nucleic Acids Res 1997, 25:2062-2067. 10.1093/nar/25.11.2062, 146718, 9153303.
41. Bousquet C, Melmed S. Critical role for STAT3 in murine pituitary adrenocorticotropin hormone leukemia inhibitory factor signaling. J Biol Chem 1999, 274:10723-10730. 10.1074/jbc.274.16.10723, 10196143.
42. Keegan AD, Nelms K, White M, Wang LM, Pierce JH, Paul WE. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 1994, 76:811-820. 10.1016/0092-8674(94)90356-5, 8124718.
43. Yokogami K, Wakisaka S, Avruch J, Reeves SA. Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr Biol 2000, 10:47-50. 10.1016/S0960-9822(99)00268-7, 10660304.
44. Ratthe C, Pelletier M, Chiasson S, Girard D. Molecular mechanisms involved in interleukin-4-induced human neutrophils: expression and regulation of suppressor of cytokine signaling. J Leukoc Biol 2007, 81:1287-1296. 10.1189/jlb.0306209, 17264307.
45. Lansac G, Dong W, Dubois CM, Benlarbi N, Afonso C, Fournier I, Salzet M, Day R. Lipopolysaccharide mediated regulation of neuroendocrine associated proprotein convertases and neuropeptide precursor processing in the rat spleen. J Neuroimmunol 2006, 171:57-71. 10.1016/j.jneuroim.2005.09.019, 16337011.
46. Mousa SA, Shakibaei M, Sitte N, Schäfer M, Stein C. Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology 2004, 145:1331-1341.
47. Vale ML, Marques JB, Moreira CA, Rocha FA, Ferreira SH, Poole S, Cunha FQ, Ribeiro RA. Antinociceptive effects of interleukin-4, -10, and -13 on the writhing response in mice and zymosan-induced knee joint incapacitation in rats. J Pharmacol Exp Ther 2003, 304:102-108. 10.1124/jpet.102.038703, 12490580.
48. Cunha FQ, Poole S, Lorenzetti BB, Veiga FH, Ferreira SH. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4. Br J Pharmacol 1999, 126:45-50. 10.1038/sj.bjp.0702266, 1565777, 10051119.
49. Zöllner C, Mousa SA, Fischer O, Rittner HL, Shaqura M, Brack A, Shakibaei M, Binder W, Urban F, Stein C, Schäfer M. Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain. J Clin Invest 2008, 118:1065-1073. 2214843, 18246198.
50. Verma-Gandhu M, Bercik P, Motomura Y, Verdu EF, Khan WI, Blennerhassett PA, Wang L, El-Sharkawy RT, Collins SM. CD4(+) T-Cell Modulation of Visceral Nociception in Mice. Gastroenterology 2006, 130:1721-1728. 10.1053/j.gastro.2006.01.045, 16697736.
51. Machelska H, Schroff M, Oswald D, Binder W, Sitte N, Mousa SA, Rittner HL, Brack A, Labuz D, Busch M, et al. Peripheral non-viral MIDGE vector-driven delivery of beta-endorphin in inflammatory pain. Mol Pain 2009, 5:72. 10.1186/1744-8069-5-72, 2797781, 20003437.
52. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110. 10.1016/0304-3959(83)90201-4, 6877845.
53. Pedranzini L, Dechow T, Berishaj M, Comenzo R, Zhou P, Azare J, Bornmann W, Bromberg J. Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells. Cancer Res 2006, 66:9714-9721. 10.1158/0008-5472.CAN-05-4280, 17018630.
54. Elder RT, Xu X, Williams JW, Gong H, Finnegan A, Chong AS. The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms. J Immunol 1997, 159:22-27.
55. Barchechath SD, Tawatao RI, Corr M, Carson DA, Cottam HB. Inhibitors of apoptosis in lymphocytes: synthesis and biological evaluation of compounds related to pifithrin-alpha. J Med Chem 2005, 48:6409-6422. 10.1021/jm0502034, 16190767.
56. Kraus J, Börner C, Höllt V. Distinct palindromic extensions of the 5′-TTC...GAA-3′ motif allow STAT6 binding in vivo. Faseb J 2003, 17:304-306.
57. Binder W, Mousa SA, Sitte N, Kaiser M, Stein C, Schäfer M. Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue. J Eur Neurosci 2004, 20:92-100.
58. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685. 10.1038/227680a0, 5432063.
59. Stein C, Hassan AH, Przewlocki R, Gramsch C, Peter K, Herz A. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci U S A 1990, 87:5935-5939. 10.1073/pnas.87.15.5935, 54444, 1974052.